Francesca Poggio
About
Francesca Poggio is a scholar working on Oncology, Cancer Research and Public Health, Environmental and Occupational Health.
According to data from OpenAlex, Francesca Poggio has authored 94 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 62 papers in Oncology, 32 papers in Cancer Research and 23 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Francesca Poggio's work include Breast Cancer Treatment Studies (30 papers), Cancer Risks and Factors (21 papers) and Reproductive Biology and Fertility (20 papers). Francesca Poggio is often cited by papers focused on Breast Cancer Treatment Studies (30 papers), Cancer Risks and Factors (21 papers) and Reproductive Biology and Fertility (20 papers). Francesca Poggio collaborates with scholars based in Italy, Belgium and United States. Francesca Poggio's co-authors include Matteo Lambertini, Lucia Del Mastro, Marcello Ceppi, Evandro de Azambuja, Marco Bruzzone, P. Pronzato, Noam Pondé, Alessia Levaggi, Claudia Bighin and Giovanni La Valle and has published in prestigious journals such as JAMA, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.
In The Last Decade
Francesca Poggio
91 papers receiving 1.7k citations
Hit Papers
Peers
Francesca Poggio
Monica Giordano Italy
Mihaela Cristea United States
Jubilee Brown United States
Shulamith Rizel Israel
Joan Murphy Canada
Christine H. Holschneider United States
Shani Paluch–Shimon Israel
Ranjit Manchanda United Kingdom
Parviz Hanjani United States
Steven C. Plaxe United States
Citations per year, relative to Francesca Poggio Francesca Poggio (= 1×)
peers
Monica Giordano
Countries citing papers authored by Francesca Poggio
Since
Specialization
Citations
This map shows the geographic impact of Francesca Poggio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Francesca Poggio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Francesca Poggio more than expected).
Fields of papers citing papers by Francesca Poggio
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Francesca Poggio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Francesca Poggio. The network helps show where Francesca Poggio may publish in the future.
Co-authorship network of co-authors of Francesca Poggio
This figure shows the co-authorship network connecting the top 25 collaborators of Francesca Poggio. A scholar is included among the top collaborators of Francesca Poggio based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Francesca Poggio. Francesca Poggio is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Poggio, Francesca, et al.. (2026). Editorial: The essential role of multidisciplinary teams in breast cancer surgery: collaboration for superior patient outcomes. Frontiers in Oncology. 15. 1754900–1754900.
2.
Blondeaux, Eva, Francesca Poggio, Alessandra Fabi, et al.. (2025). Factors associated with first-to-second-line attrition among patients with metastatic breast cancer in the real world. ESMO Open. 10(2). 104125–104125.
3.
Perachino, Marta, Lucia Del Mastro, Giulia Buzzatti, et al.. (2025). Different activity and toxicity of immunotherapy in monozygotic twins diagnosed with early triple-negative breast cancer: a case report. Therapeutic Advances in Medical Oncology. 17. 12742301–12742301.
4.
Gipponi, Marco, Federica Murelli, Marianna Pesce, et al.. (2024). Multidisciplinary and Tailored Treatment of Locally Advanced Breast Cancer in Progression during Neoadjuvant Chemotherapy: Case Report. Current Oncology. 31(5). 2856–2866.
5.
Brandão, Mariana, Diogo Martins-Branco, Claudia De Angelis, et al.. (2023). Surgery of the primary tumor in patients with de novo metastatic breast cancer: a nationwide population-based retrospective cohort study in Belgium. Breast Cancer Research and Treatment. 203(2). 351–363.
6.
Tagliamento, Marco, Marco Bruzzone, Marcello Ceppi, et al.. (2023). 186P Pooled efficacy and safety data of alectinib (A) vs. crizotinib (C) from the randomized phase III ALEX and J-ALEX trials. Annals of Oncology. 34. S255–S256.
7.
Tagliamento, Marco, Elisa Agostinetto, Roberto Borea, et al.. (2021). VISTA: A Promising Target for Cancer Immunotherapy?. SHILAP Revista de lepidopterología. Volume 10. 185–200.
8.
Tagliamento, Marco, Elisa Agostinetto, Marco Bruzzone, et al.. (2021). Mortality in adult patients with solid or hematological malignancies and SARS-CoV-2 infection with a specific focus on lung and breast cancers: A systematic review and meta-analysis. Critical Reviews in Oncology/Hematology. 163. 103365–103365.
9.
Parisi, Francesca, Maria Grazia Razeti, Eva Blondeaux, et al.. (2020). Current State of the Art in the Adjuvant Systemic Treatment of Premenopausal Patients With Early Breast Cancer. Clinical Medicine Insights Oncology. 14. 2282627560–2282627560.
10.
Poggio, Francesca, Marco Tagliamento, Davide Soldato, et al.. (2020). Update on the Management of Breast Cancer during Pregnancy. Cancers. 12(12). 3616–3616.
11.
Tagliamento, Marco, Francesco Spagnolo, Francesca Poggio, et al.. (2020). Italian survey on managing immune checkpoint inhibitors in oncology during COVID‐19 outbreak. European Journal of Clinical Investigation. 50(9). e13315–e13315.
12.
Molinelli, Chiara, Lucia Del Mastro, S. Giraudi, et al.. (2020). 226P Impact of BMI on outcome and cardiac safety in HER2-positive breast cancer patients treated with adjuvant trastuzumab: Results of a monocentric observational study. Annals of Oncology. 31. S331–S331.
13.
Lambertini, Matteo, Francesca Poggio, Marco Bruzzone, et al.. (2019). Dose‐dense adjuvant chemotherapy in HER2‐positive early breast cancer patients before and after the introduction of trastuzumab: Exploratory analysis of the GIM2 trial. International Journal of Cancer. 147(1). 160–169.
14.
Bighin, Claudia, Béatrice Dozin, Francesca Poggio, et al.. (2017). Hormonal therapy followed by chemotherapy or the reverse sequence as first-line treatment of hormone-responsive, human epidermal growth factor receptor-2 negative metastatic breast cancer patients: results of an observational study. Oncotarget. 8(27). 44800–44810.
15.
Poggio, Francesca, Marcello Ceppi, Matteo Lambertini, et al.. (2017). Concurrent versus sequential adjuvant chemo-endocrine therapy in hormone-receptor positive early stage breast cancer patients: a systematic review and meta-analysis. The Breast. 33. 104–108.
16.
Bighin, Claudia, Fabio Puglisi, Lorenzo Gerratana, et al.. (2017). Trends in the choice of first line treatment for hormone - responsive (HR+), human epidermal growth factor receptor - 2 negative (HER2-) metastatic breast cancer (MBC) patients (pts): results of a multicentric Italian observational study. Annals of Oncology. 28. vi25–vi25.
17.
Lambertini, Matteo, Arlindo R. Ferreira, Francesca Poggio, et al.. (2015). Patterns of Care and Clinical Outcomes of First-Line Trastuzumab-Based Therapy in HER2-Positive Metastatic Breast Cancer Patients Relapsing After (Neo)Adjuvant Trastuzumab: An Italian Multicenter Retrospective Cohort Study. The Oncologist. 20(8). 880–889.
18.
Rossi, Giovanni, Roberta Iadarola, Matteo Lambertini, et al.. (2015). The value of hormone serum concentration to predict the gonadotoxic effect of chemotherapy and the efficacy of LHRH analogs as a strategy to reduce treatment-related premature ovarian failure in breast cancer. Annals of Oncology. 26. vi8–vi8.
19.
Lambertini, Matteo, Luca Boni, Andrea Michelotti, et al.. (2015). Long-term outcome results of the phase III PROMISE-GIM6 study evaluating the role of LHRH analog (LHRHa) during chemotherapy as a strategy to reduce ovarian failure in early breast cancer patients. Annals of Oncology. 26. vi1–vi1.
20.
Giraudi, S., Matteo Lambertini, Paola Anserini, et al.. (2015). Prospective study of fertility preservation strategies in young early breast cancer patients: the PREFER (PREgnancy and FERtility) trial. Annals of Oncology. 26. vi10–vi10.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Monica Giordano Breakdown of academic impact, for papers by Mihaela Cristea Breakdown of academic impact, for papers by Jubilee Brown Breakdown of academic impact, for papers by Shulamith Rizel Breakdown of academic impact, for papers by Joan Murphy Breakdown of academic impact, for papers by Christine H. Holschneider Breakdown of academic impact, for papers by Shani Paluch–Shimon Breakdown of academic impact, for papers by Ranjit Manchanda Breakdown of academic impact, for papers by Parviz Hanjani Breakdown of academic impact, for papers by Steven C. Plaxe